4.6 Article

BRCA2 represses the transcriptional activity of pS2 by E2-ERa

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Cancer-causing BRCA2 missense mutations disrupt an intracellular protein assembly mechanism to disable genome maintenance

Miyoung Lee et al.

Summary: This study identified a shared molecular mechanism underlying the pathogenicity of cancer-causing missense mutations in the BRCA2 protein, involving the disruption of protein assembly and DNA repair function. Pathogenic mutations weaken the interaction between BRCA2 and partner protein DSS1, leading to the exclusion of mutant BRCA2 oligomers from the cell nucleus and impairment of homologous DNA recombination repair. The findings suggest a potential therapeutic approach for correcting the defective DNA repair in cells carrying pathogenic BRCA2 mutations.

NUCLEIC ACIDS RESEARCH (2021)

Review Cell Biology

The antitumorigenic roles of BRCA1-BARD1 in DNA repair and replication

Madalena Tarsounas et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)

Article Biochemistry & Molecular Biology

Estrogen receptors alpha (ERα) and beta (ERβ): Subtype-selective ligands and clinical potential

Ilaria Paterni et al.

STEROIDS (2014)

Article Biochemistry & Molecular Biology

Interference with BRCA2, which localizes to the centrosome during S and early M phase, leads to abnormal nuclear division

Akira Nakanishi et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)

Article Biochemistry & Molecular Biology

Genotoxic metabolites of estradiol in breast: potential mechanism of estradiol induced carcinogenesis

W Yue et al.

JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2003)

Article Biochemistry & Molecular Biology

Induction of the BRCA2 promoter by nuclear factor-κB

K Wu et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2000)